跳至主要内容
临床试验/CTRI/2022/03/041156
CTRI/2022/03/041156尚未招募2 期

Comparative clinical study of efficacy of Vatsakadi gana Vati with Chandraprabha vati in Sthaulya (Obesity) associated by PCOD

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2022年3月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
102
试验地点
2
主要终点
5.BSL before and after.

研究概览

简要总结

Does VatsakadiganaVati is the effective Ayurvedicsolution to Sthaulya (Obesity) WithPCOD in women of age group 20 to 40 years& to compare the efficacy with *ChandraprabhaVati*** because both obesity and PCOD leading to anovulation.Since its description in 1935 by Stein and Leventhal, much hasbeen learned about the pathophysiology of PCOS from its neuroendocrineinvolvement to the link between obesity, insulin resistance (IR) and PCOS.Typically, PCOS manifests as hyperandrogenemia, obesity, polycystic ovaries andchronic anovulation.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 1 Patients having BMI 25 and above 2 Patients diagnosed with PCOD.

排除标准

  • 1 Obesity with other complications like thyroid disorder, coronary heart disease etc 2 Uterine prolapse, cervical prolapse, fibroids or any other pelvic disease 3 Pregnant women and lactating mothers 4 Any anal diseases.

结局指标

主要结局

5.BSL before and after.

时间窗: 24 weeks

changes in

时间窗: 24 weeks

1.Body Mass Index: BMI

时间窗: 24 weeks

2.Measurement of circumference: - Body Girth Measurement.

时间窗: 24 weeks

3.Polycystic ovary: USG

时间窗: 24 weeks

4.Lipid profile before and after.

时间窗: 24 weeks

6.Hormonal assess –LH FSH, Testosterone, Estrogens, prolactin

时间窗: 24 weeks

次要结局

  • There is significant difference in effectiveness of Vatsakadi Gana Vati and(Chandraprabha Vati on Sthaulya (obesity) with PCOD in women)

研究者

发起方
DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE
申办方类型
Research institution and hospital

研究点 (2)

Loading locations...

相似试验

Study the efficacy of vatsakadi gana vati with... | 临床试验